EUVIMEDEUVIMED entdecken
Crossref

Antidepressants at the threshold: what is really driving prescribing around dementia diagnosis?

Chengjun Liu iD, Katharine A Wallis iD

Age and Ageing · 03.08.2026 · 55 (8)

DOI: 10.1093/ageing/afag252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Age and Ageing, online erschienen am 18.08.2026. Verfasst von Chengjun Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: General Practice Clinical Unit, Medical School, The University of Queensland, Brisbane, Queensland, Australia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

adverse effectsantidepressantsclinical guidelinesdementiaolder peoplesafe prescriptions

Autor:innen und Institutionen

  • General Practice Clinical Unit, Medical School, The University of Queensland, Brisbane, Queensland, Australia.
  • School of Nursing, Faculty of Health, Queensland University of Technology, Kelvin Grove, Queensland, Australia.

ORCID-Profile: Chengjun Liu, Katharine A Wallis

Zitieren

APA

Liu, C., & Wallis, K. A. (2026). Antidepressants at the threshold: what is really driving prescribing around dementia diagnosis?. Age and Ageing, 55(8). https://doi.org/10.1093/ageing/afag252

Vancouver

Liu C, Wallis KA. Antidepressants at the threshold: what is really driving prescribing around dementia diagnosis?. Age and Ageing. 2026;55(8). doi:10.1093/ageing/afag252

BibTeX
@article{Liu2026,
  author = {Liu, Chengjun and Wallis, Katharine A},
  title = {Antidepressants at the threshold: what is really driving prescribing around dementia diagnosis?},
  journal = {Age and Ageing},
  year = {2026},
  volume = {55},
  number = {8},
  doi = {10.1093/ageing/afag252}
}
Kostenlos starten →